PCI Pharma Services ("PCI" or the "Company"), a world-leading global contract development and manufacturing organization ...

PCI Pharma Services has received a strategic investment co-led by Bain Capital and existing lead investor Kohlberg, and ...

A Philadelphia-based pharmaceutical services company has just received a massive investment from two major private equity firms, reportedly catapulting its valuation to $10 billion.

More recently, PCI acquired a 100% stake in Ajinomoto’s fill-finish contracting arm Ajinomoto Althea. The deal, for which ...

The CDMO, which has been owned by different private investors over the last decade, will use the funds to broaden its ...

Bain Capital and Kohlberg have completed a strategic investment in PCI Pharma Services, according to a news release.

The firms lead an investment valuing PCI Pharma at $10 billion, see the company benefiting from broader trends.

Mubadala Investment Company, the Abu Dhabi-based sovereign wealth fund managing a global portfolio, is making a significant reinvestment in PCI Pharma Services (PCI).

PCI Pharma Services, which is backed by Partners Group, Thomas H. Lee Partners and Frazier Healthcare, has acquired Bellwyck Pharma Services. Iris Dorbian - 11 February 2020 ...

PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global outsourcing solutions provider today announced the launch of pci | br ...

PCI Pharma Services, a Philadelphia contract drug manufacturer, is investing $50 million into a new manufacturing facility in Rockford that's expected to create about 250 jobs.